Differences in clinical features between children and adults with dengue hemorrhagic fever/dengue shock syndrome

Vannyda Namvongsa1, Chukiat Sirivichayakul2, Sirilak Songsithichok3

  • 1Department of Medicine, University of Health Sciences, Ministry of Health, Lao PDR.

Insights

Children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) showed more severe plasma leakage and symptoms like anorexia and rash compared to adults. Adults, however, required more blood transfusions, highlighting age-related differences in DHF/DSS presentation.

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Pediatrics

Background:

  • Dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) is a significant public health concern.
  • Clinical manifestations of DHF/DSS can vary between age groups.
  • Understanding these differences is crucial for effective patient management.

Purpose of the Study:

  • To compare the clinical features of DHF/DSS in children versus adults.
  • To identify age-specific patterns in DHF/DSS presentation and severity.
  • To provide insights for clinicians managing pediatric and adult DHF/DSS patients.

Main Methods:

  • Retrospective study design.
  • Inclusion of 273 DHF/DSS patients admitted to Ratchaburi Hospital, Thailand (January 2007 - May 2008).
  • Analysis of clinical signs, symptoms, laboratory findings, and outcomes stratified by age (children vs. adults).

Main Results:

  • Common symptoms included nausea/vomiting, positive tourniquet test, anorexia, hemoconcentration, headache, abdominal tenderness, myalgia, and pleural effusion.
  • Children exhibited higher rates of anorexia, positive tourniquet test, abdominal tenderness, and convalescent rash.
  • Children showed more pronounced plasma leakage (lower serum albumin/sodium, higher pleural effusion, ascites, shock); adults required more blood transfusions.

Conclusions:

  • Significant differences exist in DHF/DSS clinical features between children and adults.
  • Children present with more severe plasma leakage and specific symptoms.
  • Adult DHF/DSS patients may have a higher need for blood transfusions, warranting tailored clinical approaches.

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.8K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
929
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967